Literature DB >> 31621487

Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys.

Christopher D Verrico1,2, David S Mathai1, Hong Gu3, Allan R Sampson3, David A Lewis4,5.   

Abstract

BACKGROUND: The relationship between adolescent cannabis use and susceptibility to persistent cognitive impairments is poorly understood. AIMS: We examined the effects of repeated exposure to Δ-9-tetrahydrocannabinol (THC) on reinforcement-related learning and performance of spatial working memory (WM) tasks of varying difficulty in adolescent monkeys.
METHODS: Seven pairs of male adolescent rhesus monkeys, matched for baseline cognitive performance, received vehicle or THC intravenously 5 days/week for 12 months. Performance on 4-item spatial WM trials was assessed throughout the 12-month study period. At the 6-month time point, more difficult novel and distractor 8-item spatial WM trials were added. Residual effects on performance were determined 23 or 71 h after THC or vehicle administration throughout the study. RESULTS/OUTCOMES: Relative to vehicle-exposed animals, repeated THC exposure was initially associated with significantly slower improvement in performance accuracy on 4-item spatial WM trials; however, this performance difference gradually diminished such that by month 12, accuracy did not significantly differ between vehicle and THC groups. Similarly, for the novel and distractor 8-item trials introduced at month 6, performance accuracy improved more slowly in the THC than in the vehicle group, despite comparable performance between groups on the 4-item task during this same period. CONCLUSIONS/
INTERPRETATION: These findings suggest that compared to vehicle exposure, THC exposure during adolescence impairs the reinforcement-related learning process required for improved performance on spatial WM tasks, but this impairment might be overcome with continued training, even in the face of ongoing THC exposure.

Entities:  

Keywords:  Cannabis; monkey; working memory; ∆-9-tetrahydrocannabiol (THC)

Mesh:

Substances:

Year:  2019        PMID: 31621487      PMCID: PMC8173701          DOI: 10.1177/0269881119882857

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  33 in total

Review 1.  The effects of adolescent cannabis use on educational attainment: a review.

Authors:  M Lynskey; W Hall
Journal:  Addiction       Date:  2000-11       Impact factor: 6.526

Review 2.  Cognitive measures in long-term cannabis users.

Authors:  Harrison G Pope; Amanda J Gruber; James I Hudson; Marilyn A Huestis; Deborah Yurgelun-Todd
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

3.  Effects of Δ-THC on Working Memory: Implications for Schizophrenia?

Authors:  Nehal P Vadhan; Mark R Serper; Margaret Haney
Journal:  Prim psychiatry       Date:  2009-01-01

4.  Delay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys.

Authors:  Christopher D Verrico; Shijing Liu; Elizabeth J Bitler; Hong Gu; Allan R Sampson; Charles W Bradberry; David A Lewis
Journal:  Neuropsychopharmacology       Date:  2012-01-04       Impact factor: 7.853

5.  Maturation of prefrontal cortex in the monkey revealed by local reversible cryogenic depression.

Authors:  P S Goldman; G E Alexander
Journal:  Nature       Date:  1977-06-16       Impact factor: 49.962

6.  A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development.

Authors:  Jean-François G Morin; Mohammad H Afzali; Josiane Bourque; Sherry H Stewart; Jean R Séguin; Maeve O'Leary-Barrett; Patricia J Conrod
Journal:  Am J Psychiatry       Date:  2018-10-03       Impact factor: 18.112

7.  Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.

Authors:  Miriam Schneider; Michael Koch
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

Review 8.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

9.  Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention.

Authors:  Christopher D Verrico; J David Jentsch; Robert H Roth; Jane R Taylor
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

Review 10.  Keep off the grass? Cannabis, cognition and addiction.

Authors:  H Valerie Curran; Tom P Freeman; Claire Mokrysz; David A Lewis; Celia J A Morgan; Loren H Parsons
Journal:  Nat Rev Neurosci       Date:  2016-04-07       Impact factor: 38.755

View more
  4 in total

1.  THC and CBD blood and brain concentrations following daily administration to adolescent primates.

Authors:  S L Withey; J Bergman; M A Huestis; S R George; B K Madras
Journal:  Drug Alcohol Depend       Date:  2020-06-18       Impact factor: 4.492

2.  Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates.

Authors:  Sarah L Withey; Brian D Kangas; Sophia Charles; Andrew B Gumbert; Jessica E Eisold; Susan R George; Jack Bergman; Bertha K Madras
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

Review 3.  Dos(e)Age: Role of Dose and Age in the Long-Term Effect of Cannabinoids on Cognition.

Authors:  Erica Zamberletti; Tiziana Rubino
Journal:  Molecules       Date:  2022-02-19       Impact factor: 4.411

4.  The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls.

Authors:  W Lawn; N Fernandez-Vinson; C Mokrysz; G Hogg; R Lees; K Trinci; K Petrilli; A Borissova; S Ofori; S Waters; P Michór; M B Wall; T P Freeman; H V Curran
Journal:  Psychopharmacology (Berl)       Date:  2022-04-29       Impact factor: 4.415

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.